SuperworthAligos Therapeutics market cap ALGS
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- n/m
- not a meaningful number
- Last meaningful
- $15.2M
- Jul 2026
- Highest close in our data
- $1.3B
- Jun 2021
Aligos Therapeutics' market cap is not a meaningful number today: no cover page share count was public by this date.
It was last meaningful in Jul 2026, at $15.2M.
On the days it had one over the last 6 years, its median was $48.7M, from $14.6M in Apr 2025 to $1.3B in Jun 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $15.2M | $14.6M | $32.8M | −58% |
| 2025 | $36.3M | $14.6M | $155.8M | −75% |
| 2024 | $147.6M | $23.2M | $147.6M | +197% |
| 2023 | $49.8M | $26.9M | $88.2M | +22% |
| 2022 | $40.8M | $38.2M | $166.6M | −92% |
| 2021 | $505.9M | $505.4M | $1.3B | −52% |
| 2020 | $1.1B | $654.9M | $1.1B | n/a |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Aligos Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.